Medicolegal Implications of Common Rhinologic Medications. Otolaryngol Clin North Am 2015 Oct;48(5):817-26
Date
06/29/2015Pubmed ID
26117297DOI
10.1016/j.otc.2015.05.009Scopus ID
2-s2.0-84940452029 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
As otolaryngologists, we prescribe many medications to our patients. The objective of this article is to review the potential side effects and medicolegal risks of the common medications used to treat chronic rhinosinusitis. The authors evaluate some of the common side effects as well as the published literature on the lawsuits associated with those medications. Finally, the authors review the informed consent discussion and opportunities to improve patient care and decrease the risk of litigation.
Author List
Poetker DM, Smith TLAuthor
David M. Poetker MD Chief, Professor in the Otolaryngology and Communication Sciences department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Adrenal Cortex HormonesAnti-Bacterial Agents
Chronic Disease
Communication
Drug Hypersensitivity
Humans
Informed Consent
Liability, Legal
Malpractice
Narcotics
Otolaryngology
Rhinitis
Sinusitis









